category,subcategory,ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
Human Diseases,Endocrine and metabolic disease,hsa04933,AGE-RAGE signaling pathway in diabetic complications,11/142,52/2914,0.21153846153846154,4.341007583965331,5.5012593551889895,2.6948137406139286e-5,0.004973143586598544,0.003995608381069507,EDN1/CCL2/VEGFA/F3/EGR1/IL1B/IL6/PIM1/NOS3/THBD/COL4A1,11
Organismal Systems,Immune system,hsa04640,Hematopoietic cell lineage,10/142,49/2914,0.20408163265306123,4.187985053176201,5.0929546019982865,8.810221548160443e-5,0.004973143586598544,0.003995608381069507,CD44/IL4R/IL1R1/CR2/IL1B/CD36/IL6/FCGR1A/CD14/ITGB3,10
Environmental Information Processing,Signal transduction,hsa04630,JAK-STAT signaling pathway,11/142,59/2914,0.1864406779661017,3.825972785867749,4.962593773891763,9.293860478757074e-5,0.004973143586598544,0.003995608381069507,IL4R/OSM/CISH/CDKN1A/LIF/IL6/MYC/PIM1/OSMR/IL12A/SOCS3,11
Environmental Information Processing,Signaling molecules and interaction,hsa04060,Cytokine-cytokine receptor interaction,17/142,127/2914,0.13385826771653545,2.746922479760453,4.55538210181937,1.0013016157940778e-4,0.004973143586598544,0.003995608381069507,TNFRSF12A/TNFRSF1A/IL4R/OSM/CCL2/IL1R1/IL1RL1/TNFRSF10B/INHA/IL1B/LIF/IL6/OSMR/CXCR1/IL12A/TNFRSF10D/RELL1,17
Human Diseases,Infectious disease: parasitic,hsa05144,Malaria,8/142,32/2914,0.25,5.130281690140845,5.316495792676924,1.0149272625711315e-4,0.004973143586598544,0.003995608381069507,CCL2/IL1B/CD36/IL6/TLR2/THBS1/IL12A/ACKR1,8
Human Diseases,Cardiovascular disease,hsa05418,Fluid shear stress and atherosclerosis,11/142,66/2914,0.16666666666666666,3.4201877934272296,4.500583700651205,2.655468034766061e-4,0.010843161141961417,0.008711798640372869,TNFRSF1A/EDN1/CCL2/VEGFA/IL1R1/IL1B/RAC2/NOS3/THBD/CDH5/ITGB3,11
Environmental Information Processing,Signal transduction,hsa04151,PI3K-Akt signaling pathway,19/142,171/2914,0.1111111111111111,2.280125195618153,3.9044098383762003,4.747882427961638e-4,0.016617588497865734,0.013351188180884608,IL4R/OSM/VEGFA/SPP1/NR4A1/CDK2/CDKN1A/IL6/MYC/TLR2/THBS1/FGF2/OSMR/NOS3/GDNF/EFNA1/BDNF/COL4A1/ITGB3,19
Cellular Processes,Cell growth and death,hsa04115,p53 signaling pathway,7/142,31/2914,0.22580645161290322,4.633802816901408,4.602965125935386,5.521944000249823e-4,0.016910953500765085,0.013586888526930489,GADD45B/BBC3/GADD45A/TNFRSF10B/CDK2/CDKN1A/THBS1,7
Human Diseases,Cancer: overview,hsa05202,Transcriptional misregulation in cancer,11/142,75/2914,0.14666666666666667,3.009765258215962,3.9903507485811085,8.290297020649848e-4,0.022568030778435697,0.018131994653351132,GADD45B/GADD45A/NR4A3/CDKN1A/IL6/MYC/BCL2A1/FCGR1A/HHEX/RUNX1/CD14,11
Organismal Systems,Immune system,hsa04613,Neutrophil extracellular trap formation,12/142,88/2914,0.13636363636363635,2.7983354673495517,3.876535527393912,9.413984076716896e-4,0.023064260987956393,0.018530684445747996,SELPLG/RAC2/SIGLEC9/TLR2/FCGR2A/FCGR1A/FPR2/FPR1/CASP4/FCGR3A/ITGB3/H4C2,12
Human Diseases,Cancer: specific types,hsa05219,Bladder cancer,5/142,18/2914,0.2777777777777778,5.700312989045384,4.526698334300696,0.001311228829538547,0.02667730104799751,0.02143353510623216,TYMP/VEGFA/CDKN1A/MYC/THBS1,5
Human Diseases,Infectious disease: bacterial,hsa05130,Pathogenic Escherichia coli infection,11/142,80/2914,0.1375,2.821654929577465,3.7387720335087384,0.0014370286156481279,0.02667730104799751,0.02143353510623216,TNFRSF1A/IL1R1/TNFRSF10B/IL1B/IL6/MYO1G/FCGR2A/TUBB6/CLDN5/CASP4/CYFIP1,11
Human Diseases,Infectious disease: bacterial,hsa05134,Legionellosis,6/142,27/2914,0.2222222222222222,4.560250391236306,4.205879584041154,0.001524417202742715,0.02667730104799751,0.02143353510623216,IL1B/IL6/TLR2/IL12A/CD14/HSPA6,6
Human Diseases,Cancer: specific types,hsa05221,Acute myeloid leukemia,6/142,27/2914,0.2222222222222222,4.560250391236306,4.205879584041154,0.001524417202742715,0.02667730104799751,0.02143353510623216,MYC/PIM1/BCL2A1/FCGR1A/RUNX1/CD14,6
Human Diseases,Infectious disease: viral,hsa05169,Epstein-Barr virus infection,10/142,71/2914,0.14084507042253522,2.8902995437413215,3.649128657366704,0.001967179259039783,0.03213059456431645,0.025814913785293995,CD44/GADD45B/HES1/GADD45A/CR2/CDK2/CDKN1A/IL6/MYC/TLR2,10
Human Diseases,Infectious disease: viral,hsa05168,Herpes simplex virus 1 infection,8/142,49/2914,0.16326530612244897,3.35038804254096,3.754854366652239,0.002151310532209476,0.032941942524457604,0.02646678088968237,TNFRSF1A/CCL2/IL1B/IL6/TLR2/IL12A/SOCS3/ITGB3,8
Organismal Systems,Development and regeneration,hsa04380,Osteoclast differentiation,9/142,65/2914,0.13846153846153847,2.8413867822318526,3.397608047378685,0.003715367039325865,0.05354499556675511,0.04302003940272055,TNFRSF1A/IL1R1/IL1B/FCGR2A/FCGR1A/FOSL1/SOCS3/FCGR3A/ITGB3,9
Cellular Processes,Transport and catabolism,hsa04145,Phagosome,9/142,66/2914,0.13636363636363635,2.7983354673495517,3.3441864778580115,0.004127028281665744,0.0561734405004504,0.045131829746871,CD36/TLR2/THBS1/FCGR2A/FCGR1A/CD14/TUBB6/FCGR3A/ITGB3,9
Human Diseases,Cardiovascular disease,hsa05417,Lipid and atherosclerosis,11/142,93/2914,0.11827956989247312,2.427230046948357,3.165568479672463,0.004844028662274575,0.0593491289196477,0.04768329584521641,TNFRSF1A/CCL2/TNFRSF10B/IL1B/CD36/IL6/TLR2/NOS3/IL12A/CD14/HSPA6,11
Human Diseases,Cancer: specific types,hsa05216,Thyroid cancer,4/142,15/2914,0.26666666666666666,5.472300469483567,3.929798631927235,0.004844826850583486,0.0593491289196477,0.04768329584521641,GADD45B/GADD45A/CDKN1A/MYC,4
Human Diseases,Infectious disease: bacterial,hsa05150,Staphylococcus aureus infection,6/142,35/2914,0.17142857142857143,3.517907444668008,3.391335477671502,0.006059011242865955,0.06871948101152946,0.05521178495877985,SELPLG/FCGR2A/FCGR1A/FPR2/FPR1/FCGR3A,6
Human Diseases,Immune disease,hsa05321,Inflammatory bowel disease,5/142,25/2914,0.2,4.104225352112676,3.527502062949786,0.006170728907157747,0.06871948101152946,0.05521178495877985,IL4R/IL1B/IL6/TLR2/IL12A,5
Environmental Information Processing,Signal transduction,hsa04064,NF-kappa B signaling pathway,7/142,47/2914,0.14893617021276595,3.056338028169014,3.2162321662390854,0.006868715628555452,0.07000757325433382,0.05624668613774619,TNFRSF1A/GADD45B/IL1R1/GADD45A/IL1B/BCL2A1/CD14,7
Human Diseases,Cancer: specific types,hsa05222,Small cell lung cancer,6/142,36/2914,0.16666666666666666,3.4201877934272296,3.3065319483669717,0.006985192730457699,0.07000757325433382,0.05624668613774619,GADD45B/GADD45A/CDK2/CDKN1A/MYC/COL4A1,6
Environmental Information Processing,Signal transduction,hsa04010,MAPK signaling pathway,15/142,155/2914,0.0967741935483871,1.9859154929577465,2.854614659182075,0.00735066984096335,0.07000757325433382,0.05624668613774619,TNFRSF1A/GADD45B/VEGFA/IL1R1/GADD45A/NR4A1/IL1B/RAC2/MYC/FGF2/GDNF/EFNA1/CD14/HSPA6/BDNF,15
Human Diseases,Infectious disease: viral,hsa05166,Human T-cell leukemia virus 1 infection,10/142,85/2914,0.11764705882352941,2.4142502071251033,2.9945877362255167,0.007429375120868079,0.07000757325433382,0.05624668613774619,TNFRSF1A/IL1R1/EGR1/EGR2/CDK2/CDKN1A/ZFP36/IL6/MYC/FOSL1,10
Human Diseases,Infectious disease: parasitic,hsa05146,Amoebiasis,7/142,48/2914,0.14583333333333334,2.9926643192488265,3.150173483821068,0.007721133810268699,0.07006214013021597,0.056290527193771804,IL1R1/IL1B/IL6/TLR2/IL12A/CD14/COL4A1,7
Environmental Information Processing,Signaling molecules and interaction,hsa04061,Viral protein interaction with cytokine and cytokine receptor,6/142,37/2914,0.16216216216216217,3.3277502854967644,3.224668841301468,0.008009932435485331,0.07008690881049665,0.05631042727202094,TNFRSF1A/CCL2/TNFRSF10B/IL6/CXCR1/TNFRSF10D,6
Environmental Information Processing,Signal transduction,hsa04066,HIF-1 signaling pathway,7/142,49/2914,0.14285714285714285,2.93158953722334,3.085804248979216,0.00864943768994524,0.07079775721997562,0.05688154930240793,EDN1/VEGFA/CDKN1A/IL6/PDK1/HK2/NOS3,7
Human Diseases,Cancer: specific types,hsa05220,Chronic myeloid leukemia,5/142,27/2914,0.18518518518518517,3.8002086593635886,3.3080090266861406,0.008669113128976608,0.07079775721997562,0.05688154930240793,GADD45B/GADD45A/CDKN1A/MYC/RUNX1,5
Human Diseases,Cancer: specific types,hsa05210,Colorectal cancer,6/142,38/2914,0.15789473684210525,3.2401779095626386,3.1455577964674792,0.009138777876317674,0.07222582515154291,0.0580289121518304,GADD45B/BBC3/GADD45A/CDKN1A/RAC2/MYC,6
Human Diseases,Endocrine and metabolic disease,hsa04931,Insulin resistance,6/142,39/2914,0.15384615384615385,3.1570964247020585,3.069027214472925,0.010377191785571498,0.07709202745382686,0.06193859993067937,TNFRSF1A/SLC27A6/CD36/IL6/NOS3/SOCS3,6
Environmental Information Processing,Signal transduction,hsa04668,TNF signaling pathway,8/142,63/2914,0.12698412698412698,2.6058573664207465,2.916059867145538,0.010383824106025659,0.07709202745382686,0.06193859993067937,TNFRSF1A/EDN1/CCL2/IRF1/IL1B/LIF/IL6/SOCS3,8
Human Diseases,Cancer: overview,hsa05205,Proteoglycans in cancer,10/142,91/2914,0.10989010989010989,2.2550688747871845,2.7526476151074593,0.01188603648485478,0.0834926740007622,0.067081117242288,PLAUR/CD44/WNT8A/VEGFA/CDKN1A/MYC/TLR2/THBS1/FGF2/ITGB3,10
Human Diseases,Infectious disease: viral,hsa05162,Measles,7/142,52/2914,0.1346153846153846,2.7624593716143013,2.9020425313510136,0.011927524857251742,0.0834926740007622,0.067081117242288,BBC3/CDK2/IL1B/IL6/TLR2/IL12A/HSPA6,7
Human Diseases,Infectious disease: parasitic,hsa05140,Leishmaniasis,6/142,41/2914,0.14634146341463414,3.0030917210580554,2.923093807401568,0.013204008229364074,0.08986061156094995,0.07219735493833573,IL1B/TLR2/FCGR2A/FCGR1A/IL12A/FCGR3A,6
Human Diseases,Infectious disease: bacterial,hsa05152,Tuberculosis,9/142,80/2914,0.1125,2.30862676056338,2.685830919597028,0.014483050405293916,0.09574862785223001,0.07692800605098611,TNFRSF1A/IL1B/IL6/TLR2/FCGR2A/FCGR1A/IL12A/CD14/FCGR3A,9
Human Diseases,Cancer: specific types,hsa05212,Pancreatic cancer,5/142,31/2914,0.16129032258064516,3.3098591549295775,2.9259158164860595,0.01560589988828615,0.09574862785223001,0.07692800605098611,GADD45B/VEGFA/GADD45A/CDKN1A/RAC2,5
Human Diseases,Infectious disease: viral,hsa05163,Human cytomegalovirus infection,10/142,95/2914,0.10526315789473684,2.1601186063750926,2.601563665693651,0.015825960460083617,0.09574862785223001,0.07692800605098611,TNFRSF1A/CCL2/VEGFA/IL1R1/CDKN1A/IL1B/RAC2/IL6/MYC/ITGB3,10
Environmental Information Processing,Signal transduction,hsa04068,FoxO signaling pathway,7/142,55/2914,0.12727272727272726,2.611779769526248,2.7308495163224826,0.016023239763026248,0.09574862785223001,0.07692800605098611,GADD45B/GADD45A/CDK2/CDKN1A/IL6/PLK4/DEPP1,7
Cellular Processes,Cell growth and death,hsa04210,Apoptosis,7/142,55/2914,0.12727272727272726,2.611779769526248,2.7308495163224826,0.016023239763026248,0.09574862785223001,0.07692800605098611,TNFRSF1A/GADD45B/BBC3/GADD45A/TNFRSF10B/BCL2A1/CASP12,7
Human Diseases,Infectious disease: viral,hsa05164,Influenza A,7/142,56/2914,0.125,2.5651408450704225,2.6762958957235705,0.017586905499865902,0.1025902820825511,0.08242484532518606,TNFRSF1A/CCL2/TNFRSF10B/IL1B/IL6/IL12A/SOCS3,7
Human Diseases,Infectious disease: bacterial,hsa05132,Salmonella infection,10/142,98/2914,0.10204081632653061,2.0939925265881003,2.493037834016447,0.01936690746142316,0.11034633321043429,0.08865634504984408,TNFRSF1A/TNFRSF10B/IL1B/IL6/MYC/TLR2/CD14/TUBB6/CASP4/CYFIP1,10
Human Diseases,Cancer: overview,hsa05230,Central carbon metabolism in cancer,5/142,33/2914,0.15151515151515152,3.109261630388391,2.7576147590915716,0.020165972268111107,0.1110557357825784,0.08922630544078265,SLC1A5/MYC/SLC16A3/PDK1/HK2,5
Organismal Systems,Immune system,hsa04620,Toll-like receptor signaling pathway,6/142,45/2914,0.13333333333333333,2.7361502347417836,2.656110188170246,0.020397992286596032,0.1110557357825784,0.08922630544078265,SPP1/IL1B/IL6/TLR2/IL12A/CD14,6
Organismal Systems,Immune system,hsa04659,Th17 cell differentiation,5/142,35/2914,0.14285714285714285,2.93158953722334,2.6016318192141936,0.02552234337992161,0.13435754866270053,0.10794784790515577,IL4R/IL1R1/IL1B/IL6/RUNX1,5
Human Diseases,Cancer: specific types,hsa05224,Breast cancer,8/142,74/2914,0.10810810810810811,2.2185001903311763,2.402703011590815,0.025774713416926227,0.13435754866270053,0.10794784790515577,WNT8A/GADD45B/HES1/GADD45A/CDKN1A/MYC/FGF2/HEYL,8
Human Diseases,Infectious disease: parasitic,hsa05142,Chagas disease,6/142,49/2914,0.12244897959183673,2.51279103190572,2.4167541313061927,0.02988391272146545,0.15079857535425903,0.12115717976905023,TNFRSF1A/CCL2/IL1B/IL6/TLR2/IL12A,6
Human Diseases,Cancer: overview,hsa05200,Pathways in cancer,19/142,249/2914,0.07630522088353414,1.5658691102437923,2.112928765453013,0.030520096818422215,0.15079857535425903,0.12115717976905023,WNT8A/IL4R/EDN1/GADD45B/BBC3/VEGFA/HES1/GADD45A/CDK2/CDKN1A/RAC2/IL6/MYC/PIM1/FGF2/RUNX1/HEYL/IL12A/COL4A1,19
Organismal Systems,Digestive system,hsa04978,Mineral absorption,4/142,25/2914,0.16,3.2833802816901407,2.5947306463040802,0.030775219460052863,0.15079857535425903,0.12115717976905023,MT2A/MT1X/MT1A/MT1M,4
Organismal Systems,Immune system,hsa04657,IL-17 signaling pathway,5/142,37/2914,0.13513513513513514,2.7731252379139706,2.456338096939041,0.031715686692964366,0.15235967136816214,0.12241142232372211,CCL2/IL1B/IL6/S100A9/FOSL1,5
Human Diseases,Infectious disease: viral,hsa05161,Hepatitis B,7/142,64/2914,0.109375,2.2444982394366195,2.278135989948198,0.034131860391458456,0.16081357299821772,0.12920360107697837,EGR2/CDK2/CDKN1A/IL6/MYC/TLR2/CASP12,7
Human Diseases,Cancer: specific types,hsa05226,Gastric cancer,7/142,66/2914,0.10606060606060606,2.1764831412718735,2.1877892550648173,0.03949052282188193,0.17975948589224078,0.1444254516083739,WNT8A/GADD45B/GADD45A/CDK2/CDKN1A/MYC/FGF2,7
Human Diseases,Cancer: specific types,hsa05213,Endometrial cancer,4/142,27/2914,0.14814814814814814,3.040166927490871,2.410138469331128,0.039620458115024494,0.17975948589224078,0.1444254516083739,GADD45B/GADD45A/CDKN1A/MYC,4
Human Diseases,Cancer: overview,hsa05206,MicroRNAs in cancer,8/142,81/2914,0.09876543209876543,2.0267779516605806,2.1208676025772597,0.04138415612707918,0.1832789520487596,0.14725312151715594,CD44/VEGFA/CDKN1A/MYC/PIM1/THBS1/EFNA1/ITGB3,8
Cellular Processes,Cell growth and death,hsa04218,Cellular senescence,6/142,53/2914,0.11320754716981132,2.3231464257241563,2.1999089946163704,0.041892331896859335,0.1832789520487596,0.14725312151715594,GADD45B/GADD45A/CDK2/CDKN1A/IL6/MYC,6
Organismal Systems,Immune system,hsa04610,Complement and coagulation cascades,5/142,40/2914,0.125,2.5651408450704225,2.255577950951908,0.04264134739030495,0.18328298439692478,0.1472563612555314,PLAUR/CR2/F3/F12/THBD,5
Organismal Systems,Endocrine system,hsa04920,Adipocytokine signaling pathway,4/142,29/2914,0.13793103448275862,2.830500242836328,2.2418868137764476,0.04977078579279901,0.21023866412475448,0.16891355613890047,TNFRSF1A/CD36/SOCS3/ACSL5,4
Human Diseases,Infectious disease: bacterial,hsa05133,Pertussis,5/142,42/2914,0.11904761904761904,2.4429912810194496,2.1316403670381816,0.05104434865279038,0.21196382067684139,0.1702996110271508,IRF1/IL1B/IL6/IL12A/CD14,5
Organismal Systems,Endocrine system,hsa03320,PPAR signaling pathway,4/142,30/2914,0.13333333333333333,2.7361502347417836,2.1630576988524948,0.055334081538302646,0.22358466894030685,0.17963623240316812,SLC27A6/CD36/ANGPTL4/ACSL5,4
Human Diseases,Infectious disease: viral,hsa05165,Human papillomavirus infection,12/142,149/2914,0.08053691275167785,1.6527081954816145,1.8508977765078485,0.05626015611509107,0.22358466894030685,0.17963623240316812,WNT8A/TNFRSF1A/VEGFA/HES1/SPP1/CDK2/CDKN1A/IRF1/THBS1/HEYL/COL4A1/ITGB3,12
Human Diseases,Infectious disease: viral,hsa05160,Hepatitis C,6/142,57/2914,0.10526315789473684,2.1601186063750926,2.0017161881722907,0.05658061009917969,0.22358466894030685,0.17963623240316812,TNFRSF1A/CDK2/CDKN1A/MYC/CLDN5/SOCS3,6
Organismal Systems,Immune system,hsa04666,Fc gamma R-mediated phagocytosis,5/142,44/2914,0.11363636363636363,2.3319462227912933,2.014604881794041,0.060353515046034485,0.22994366735235786,0.18474528805538526,RAC2/FCGR2A/FCGR1A/LIMK2/FCGR3A,5
Environmental Information Processing,Signaling molecules and interaction,hsa04512,ECM-receptor interaction,6/142,58/2914,0.10344827586206896,2.1228751821272462,1.9547183047889496,0.06068234378817469,0.22994366735235786,0.18474528805538526,CD44/SPP1/CD36/THBS1/COL4A1/ITGB3,6
Human Diseases,Cancer: specific types,hsa05218,Melanoma,4/142,31/2914,0.12903225806451613,2.647887323943662,2.087391161761396,0.061219738079045814,0.22994366735235786,0.18474528805538526,GADD45B/GADD45A/CDKN1A/FGF2,4
Human Diseases,Infectious disease: parasitic,hsa05143,African trypanosomiasis,3/142,19/2914,0.15789473684210525,3.2401779095626386,2.2169343283244385,0.06194400834798212,0.22994366735235786,0.18474528805538526,IL1B/IL6/IL12A,3
Human Diseases,Immune disease,hsa05323,Rheumatoid arthritis,5/142,45/2914,0.1111111111111111,2.280125195618153,1.9584443247911134,0.06534795539096429,0.23895894135501866,0.19198849423582598,CCL2/VEGFA/IL1B/IL6/TLR2,5
Organismal Systems,Immune system,hsa04625,C-type lectin receptor signaling pathway,5/142,46/2914,0.10869565217391304,2.2305572565829763,1.9037458502136981,0.07056789686802911,0.25425198136275196,0.2042754909337685,EGR2/IRF1/IL1B/IL6/IL12A,5
Metabolism,Glycan biosynthesis and metabolism,hsa00532,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,2/142,10/2914,0.2,4.104225352112676,2.225218884615042,0.08209140359535444,0.28327315325157515,0.22759217898193154,XYLT1/CHST3,2
Human Diseases,Endocrine and metabolic disease,hsa04940,Type I diabetes mellitus,2/142,10/2914,0.2,4.104225352112676,2.225218884615042,0.08209140359535444,0.28327315325157515,0.22759217898193154,IL1B/IL12A,2
Human Diseases,Immune disease,hsa05332,Graft-versus-host disease,2/142,10/2914,0.2,4.104225352112676,2.225218884615042,0.08209140359535444,0.28327315325157515,0.22759217898193154,IL1B/IL6,2
Human Diseases,Infectious disease: viral,hsa05167,Kaposi sarcoma-associated herpesvirus infection,7/142,79/2914,0.08860759493670886,1.8183276876448562,1.6687145822549254,0.08755691907680045,0.29793673852522373,0.23937344835324104,TNFRSF1A/VEGFA/CDKN1A/ZFP36/IL6/MYC/FGF2,7
Cellular Processes,Cell growth and death,hsa04110,Cell cycle,5/142,50/2914,0.1,2.052112676056338,1.6981597774436827,0.09366601790058207,0.30933899949608623,0.2485344485747288,GADD45B/GADD45A/CDK2/CDKN1A/MYC,5
Human Diseases,Neurodegenerative disease,hsa05020,Prion disease,7/142,81/2914,0.08641975308641975,1.773430707703008,1.5975646225679343,0.09703788987005056,0.30933899949608623,0.2485344485747288,EGR1/IL1B/RAC2/IL6/HSPA6/TUBB6/CASP12,7
Human Diseases,Drug resistance: antineoplastic,hsa01523,Antifolate resistance,2/142,11/2914,0.18181818181818182,3.7311139564660696,2.0536690012344923,0.09722082841305568,0.30933899949608623,0.2485344485747288,IL1B/IL6,2
Environmental Information Processing,Signal transduction,hsa04392,Hippo signaling pathway - multiple species,2/142,11/2914,0.18181818181818182,3.7311139564660696,2.0536690012344923,0.09722082841305568,0.30933899949608623,0.2485344485747288,TEAD3/TEAD4,2
Human Diseases,Endocrine and metabolic disease,hsa04950,Maturity onset diabetes of the young,2/142,11/2914,0.18181818181818182,3.7311139564660696,2.0536690012344923,0.09722082841305568,0.30933899949608623,0.2485344485747288,HES1/HHEX,2
Human Diseases,Cancer: specific types,hsa05217,Basal cell carcinoma,4/142,37/2914,0.10810810810810811,2.2185001903311763,1.6880073525766144,0.1030307576915289,0.32362225172339204,0.2600101442417801,WNT8A/GADD45B/GADD45A/CDKN1A,4
Human Diseases,Infectious disease: viral,hsa05171,Coronavirus disease - COVID-19,7/142,84/2914,0.08333333333333333,1.7100938967136148,1.4944452420570995,0.11228537944373909,0.3462480916475514,0.2781885849112443,TNFRSF1A/CCL2/IL1B/IL6/TLR2/FCGR2A/IL12A,7
Cellular Processes,Cell growth and death,hsa04215,Apoptosis - multiple species,2/142,12/2914,0.16666666666666666,3.4201877934272296,1.9011167431175673,0.1130606013543025,0.3462480916475514,0.2781885849112443,TNFRSF1A/BBC3,2
Human Diseases,Infectious disease: bacterial,hsa05131,Shigellosis,7/142,87/2914,0.08045977011494253,1.651125141654525,1.3953366080267633,0.12873169348619182,0.38937364079156783,0.3128372538260932,CD44/TNFRSF1A/IL1R1/IL1B/HK2/CD14/CASP4,7
Human Diseases,Endocrine and metabolic disease,hsa04932,Non-alcoholic fatty liver disease,4/142,41/2914,0.0975609756097561,2.002061147372037,1.4622988571755056,0.13655237829820935,0.4079918619885523,0.3277958246696425,TNFRSF1A/IL1B/IL6/SOCS3,4
Organismal Systems,Immune system,hsa04623,Cytosolic DNA-sensing pathway,3/142,27/2914,0.1111111111111111,2.280125195618153,1.5122679119761158,0.14164113841076276,0.41809733627273343,0.3359149382728299,IL1B/IL6/IFI16,3
Environmental Information Processing,Signal transduction,hsa04015,Rap1 signaling pathway,8/142,107/2914,0.07476635514018691,1.534289851257075,1.274281590671364,0.14765396211074133,0.4306573894896622,0.34600615181339134,VEGFA/ARAP3/RAC2/THBS1/FGF2/EFNA1/FPR1/ITGB3,8
Environmental Information Processing,Signal transduction,hsa04370,VEGF signaling pathway,3/142,30/2914,0.1,2.052112676056338,1.3108199846209954,0.17745086904552096,0.5057131905575898,0.4063087717906308,VEGFA/RAC2/NOS3,3
Organismal Systems,Immune system,hsa04621,NOD-like receptor signaling pathway,6/142,78/2914,0.07692307692307693,1.5785482123510293,1.172064590637379,0.17753898185826283,0.5057131905575898,0.4063087717906308,CCL2/IL1B/IL6/IFI16/CASP4/CASP12,6
Genetic Information Processing,Transcription,hsa03040,Spliceosome,2/142,16/2914,0.125,2.5651408450704225,1.4206334214517609,0.18156494943426477,0.5057131905575898,0.4063087717906308,HSPA6/RNVU1-27,2
Human Diseases,Endocrine and metabolic disease,hsa04936,Alcoholic liver disease,5/142,62/2914,0.08064516129032258,1.6549295774647887,1.1795965396177048,0.18219984005029227,0.5057131905575898,0.4063087717906308,TNFRSF1A/IL1B/IL6/IL12A/CD14,5
Human Diseases,Infectious disease: parasitic,hsa05145,Toxoplasmosis,4/142,46/2914,0.08695652173913043,1.784445805266381,1.213584689785393,0.18370805697806325,0.5057131905575898,0.4063087717906308,TNFRSF1A/TLR2/IL12A/HSPA6,4
Organismal Systems,Endocrine system,hsa04917,Prolactin signaling pathway,3/142,31/2914,0.0967741935483871,1.9859154929577465,1.2488665070367326,0.18990420450621473,0.5169614456002513,0.4153460379258732,CISH/IRF1/SOCS3,3
Organismal Systems,Digestive system,hsa04975,Fat digestion and absorption,2/142,17/2914,0.11764705882352941,2.4142502071251033,1.3234095541487065,0.19955496931473687,0.5372633789242917,0.4316573656663481,PLA2G5/CD36,2
Human Diseases,Cancer: specific types,hsa05214,Glioma,3/142,32/2914,0.09375,1.923855633802817,1.1891863457831269,0.20257456138576374,0.5394648645599143,0.4334261210427668,GADD45B/GADD45A/CDKN1A,3
Environmental Information Processing,Signal transduction,hsa04350,TGF-beta signaling pathway,4/142,49/2914,0.08163265306122448,1.67519402127048,1.0786538959601455,0.21425464557623045,0.553663907147158,0.44483415955539657,HAMP/MYC/LRRC32/THBS1,4
Human Diseases,Cancer: specific types,hsa05223,Non-small cell lung cancer,3/142,33/2914,0.09090909090909091,1.8655569782330348,1.131615283577035,0.21543777264483505,0.553663907147158,0.44483415955539657,GADD45B/GADD45A/CDKN1A,3
Human Diseases,Infectious disease: bacterial,hsa05135,Yersinia infection,5/142,66/2914,0.07575757575757576,1.5546308151941954,1.0313920322716235,0.21694585749439657,0.553663907147158,0.44483415955539657,CCL2/IL1B/RAC2/IL6/FCGR2A,5
Human Diseases,Cancer: specific types,hsa05225,Hepatocellular carcinoma,5/142,66/2914,0.07575757575757576,1.5546308151941954,1.0313920322716235,0.21694585749439657,0.553663907147158,0.44483415955539657,WNT8A/GADD45B/GADD45A/CDKN1A/MYC,5
Metabolism,Lipid metabolism,hsa00061,Fatty acid biosynthesis,1/142,5/2914,0.2,4.104225352112676,1.5721145406040997,0.2211712673538847,0.5586284587804304,0.44882286484184963,ACSL5,1
Cellular Processes,Cellular community - eukaryotes,hsa04510,Focal adhesion,7/142,103/2914,0.06796116504854369,1.3946396827567344,0.9227982121066365,0.23416213480496312,0.5854053370124078,0.4703364039584115,VEGFA/SPP1/RAC2/EMP1/THBS1/COL4A1/ITGB3,7
Human Diseases,Drug resistance: antineoplastic,hsa01521,EGFR tyrosine kinase inhibitor resistance,3/142,35/2914,0.08571428571428572,1.758953722334004,1.0222245022995768,0.24164887806530222,0.5980199507676671,0.48047145346317405,VEGFA/IL6/FGF2,3
Environmental Information Processing,Signal transduction,hsa04390,Hippo signaling pathway,5/142,70/2914,0.07142857142857142,1.46579476861167,0.8926817006544212,0.25358200925469637,0.6165176025799041,0.49533315438213565,TEAD3/WNT8A/BBC3/MYC/TEAD4,5
Human Diseases,Endocrine and metabolic disease,hsa04930,Type II diabetes mellitus,2/142,20/2914,0.1,2.052112676056338,1.0684292992957523,0.2544875156071483,0.6165176025799041,0.49533315438213565,HK2/SOCS3,2
Metabolism,Metabolism of cofactors and vitamins,hsa00860,Porphyrin metabolism,1/142,6/2914,0.16666666666666666,3.4201877934272296,1.3429050030576262,0.25918903292134743,0.6165176025799041,0.49533315438213565,CP,1
Genetic Information Processing,Transcription,hsa03020,RNA polymerase,1/142,6/2914,0.16666666666666666,3.4201877934272296,1.3429050030576262,0.25918903292134743,0.6165176025799041,0.49533315438213565,POLR2A,1
Human Diseases,Immune disease,hsa05322,Systemic lupus erythematosus,4/142,55/2914,0.07272727272727272,1.4924455825864276,0.8343539275322742,0.2789097433617088,0.6570469915732564,0.5278959717473639,FCGR2A/FCGR1A/FCGR3A/H4C2,4
Organismal Systems,Digestive system,hsa04973,Carbohydrate digestion and absorption,2/142,22/2914,0.09090909090909091,1.8655569782330348,0.9222011505172334,0.291360016692807,0.679840038949883,0.5462087530982948,SLC2A5/HK2,2
Environmental Information Processing,Signal transduction,hsa04330,Notch signaling pathway,2/142,23/2914,0.08695652173913043,1.784445805266381,0.8547136084864252,0.30973172879116095,0.7158893731493815,0.575172127943864,HES1/HEYL,2
Metabolism,Carbohydrate metabolism,hsa00052,Galactose metabolism,1/142,8/2914,0.125,2.5651408450704225,1.0031558619732415,0.32978324528661496,0.7412559183047768,0.5955525530526027,HK2,1
Metabolism,Lipid metabolism,hsa00592,alpha-Linolenic acid metabolism,1/142,8/2914,0.125,2.5651408450704225,1.0031558619732415,0.32978324528661496,0.7412559183047768,0.5955525530526027,PLA2G5,1
Human Diseases,Immune disease,hsa05330,Allograft rejection,1/142,8/2914,0.125,2.5651408450704225,1.0031558619732415,0.32978324528661496,0.7412559183047768,0.5955525530526027,IL12A,1
Metabolism,Global and overview maps,hsa01240,Biosynthesis of cofactors,3/142,42/2914,0.07142857142857142,1.46579476861167,0.6880893492484392,0.3362097547160775,0.7488308173221726,0.6016385084392966,MTHFD2/BCO1/PDXP,3
Cellular Processes,Cell growth and death,hsa04216,Ferroptosis,2/142,25/2914,0.08,1.6416901408450704,0.729187813012669,0.34615585502803137,0.7572159328738186,0.6083754219007694,CP/ACSL5,2
Human Diseases,Cancer: specific types,hsa05211,Renal cell carcinoma,2/142,25/2914,0.08,1.6416901408450704,0.729187813012669,0.34615585502803137,0.7572159328738186,0.6083754219007694,VEGFA/CDKN1A,2
Genetic Information Processing,Replication and repair,hsa03420,Nucleotide excision repair,1/142,9/2914,0.1111111111111111,2.280125195618153,0.870399100229884,0.36253299723750976,0.774960094010951,0.6226317404083689,POLR2A,1
Metabolism,Lipid metabolism,hsa00590,Arachidonic acid metabolism,2/142,26/2914,0.07692307692307693,1.5785482123510293,0.6705720335704028,0.3641433840081343,0.774960094010951,0.6226317404083689,PLA2G5/ALOX12B,2
Human Diseases,Substance dependence,hsa05033,Nicotine addiction,2/142,26/2914,0.07692307692307693,1.5785482123510293,0.6705720335704028,0.3641433840081343,0.774960094010951,0.6226317404083689,GABRE/GABRA6,2
NA,NA,hsa04382,Cornified envelope formation,4/142,63/2914,0.06349206349206349,1.3029286832103733,0.5500850786554649,0.3688448517300026,0.774960094010951,0.6226317404083689,S100A9/ALOX12B/CLDN5/COL4A1,4
Environmental Information Processing,Signaling molecules and interaction,hsa04080,Neuroactive ligand-receptor interaction,11/142,198/2914,0.05555555555555555,1.1400625978090766,0.461963529744495,0.37008298367053577,0.774960094010951,0.6226317404083689,EDN1/GABRE/EDN3/CHRNA10/HCRTR2/GABRA6/CHRNB3/ADM/FPR2/FPR1/OXTR,11
Environmental Information Processing,Signal transduction,hsa04310,Wnt signaling pathway,5/142,83/2914,0.060240963855421686,1.2362124554556253,0.4940713912794434,0.3800338735651212,0.7778615137554099,0.6249628488604153,WNT8A/RAC2/MYC/VANGL1/FOSL1,5
Human Diseases,Drug resistance: antineoplastic,hsa01524,Platinum drug resistance,2/142,27/2914,0.07407407407407407,1.5200834637454355,0.6143973546211032,0.3819435636559243,0.7778615137554099,0.6249628488604153,BBC3/CDKN1A,2
Organismal Systems,Nervous system,hsa04727,GABAergic synapse,3/142,46/2914,0.06521739130434782,1.3383343539497856,0.523423529357088,0.39041552701346083,0.7778615137554099,0.6249628488604153,SLC38A5/GABRE/GABRA6,3
Organismal Systems,Circulatory system,hsa04270,Vascular smooth muscle contraction,4/142,65/2914,0.06153846153846154,1.2628385698808235,0.48497276552957697,0.3914315078326319,0.7778615137554099,0.6249628488604153,EDN1/EDN3/PLA2G5/ADM,4
Cellular Processes,Cellular community - eukaryotes,hsa04550,Signaling pathways regulating pluripotency of stem cells,4/142,65/2914,0.06153846153846154,1.2628385698808235,0.48497276552957697,0.3914315078326319,0.7778615137554099,0.6249628488604153,WNT8A/LIF/MYC/FGF2,4
Genetic Information Processing,"Folding, sorting and degradation",hsa04130,SNARE interactions in vesicular transport,1/142,10/2914,0.1,2.052112676056338,0.7541917000033741,0.3936931743088605,0.7778615137554099,0.6249628488604153,STX11,1
Organismal Systems,Endocrine system,hsa04614,Renin-angiotensin system,1/142,10/2914,0.1,2.052112676056338,0.7541917000033741,0.3936931743088605,0.7778615137554099,0.6249628488604153,ENPEP,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04141,Protein processing in endoplasmic reticulum,2/142,28/2914,0.07142857142857142,1.46579476861167,0.5604582423133974,0.39953197755772407,0.7830826760131392,0.6291577246593213,HSPA6/CASP12,2
Environmental Information Processing,Signal transduction,hsa04014,Ras signaling pathway,6/142,105/2914,0.05714285714285714,1.1726358148893359,0.40772513067120864,0.40519320042368157,0.7878756674904919,0.6330085921405886,VEGFA/PLA2G5/RAC2/FGF2/EFNA1/BDNF,6
Organismal Systems,Digestive system,hsa04979,Cholesterol metabolism,2/142,29/2914,0.06896551724137931,1.415250121418164,0.508573421538568,0.41688699883645963,0.8011287671058187,0.6436566249142347,CD36/ANGPTL4,2
Metabolism,Lipid metabolism,hsa00591,Linoleic acid metabolism,1/142,11/2914,0.09090909090909091,1.8655569782330348,0.6508580613382638,0.42334040889844105,0.8011287671058187,0.6436566249142347,PLA2G5,1
Genetic Information Processing,Replication and repair,hsa03460,Fanconi anemia pathway,1/142,11/2914,0.09090909090909091,1.8655569782330348,0.6508580613382638,0.42334040889844105,0.8011287671058187,0.6436566249142347,HES1,1
Human Diseases,Cancer: overview,hsa05203,Viral carcinogenesis,4/142,68/2914,0.058823529411764705,1.2071251035625516,0.391099759228741,0.4250887335663528,0.8011287671058187,0.6436566249142347,EGR2/CDK2/CDKN1A/H4C2,4
Organismal Systems,Endocrine system,hsa04926,Relaxin signaling pathway,4/142,69/2914,0.057971014492753624,1.189630536844254,0.36075261351597504,0.4362159464570483,0.8158237166563117,0.6554630935111936,EDN1/VEGFA/NOS3/COL4A1,4
Human Diseases,Endocrine and metabolic disease,hsa04934,Cushing syndrome,4/142,70/2914,0.05714285714285714,1.1726358148893359,0.3308513603289388,0.4472846699238575,0.8301874555404931,0.6670034551496121,WNT8A/NR4A1/CDK2/CDKN1A,4
Human Diseases,Cancer: specific types,hsa05215,Prostate cancer,2/142,31/2914,0.06451612903225806,1.323943661971831,0.4103418523120692,0.45082305367578457,0.8304635199290769,0.6672252555391509,CDK2/CDKN1A,2
Human Diseases,Cardiovascular disease,hsa05410,Hypertrophic cardiomyopathy,3/142,51/2914,0.058823529411764705,1.2071251035625516,0.33769525173292747,0.4565222378445477,0.834686181133688,0.6706178984833497,EDN1/IL6/ITGB3,3
Cellular Processes,Cellular community - eukaryotes,hsa04520,Adherens junction,2/142,32/2914,0.0625,1.2825704225352113,0.36372445640436757,0.46737295316178606,0.845138527242795,0.6790157018019449,RAC2/CDH5,2
Metabolism,Amino acid metabolism,hsa00220,Arginine biosynthesis,1/142,13/2914,0.07692307692307693,1.5785482123510293,0.4731024197224519,0.4783844083384028,0.845138527242795,0.6790157018019449,NOS3,1
Organismal Systems,Immune system,hsa04670,Leukocyte transendothelial migration,3/142,53/2914,0.05660377358490566,1.1615732128620782,0.2686372100274661,0.4821533117736089,0.845138527242795,0.6790157018019449,RAC2/CDH5/CLDN5,3
Environmental Information Processing,Signal transduction,hsa04071,Sphingolipid signaling pathway,3/142,54/2914,0.05555555555555555,1.1400625978090766,0.2351006565976071,0.4947574274260227,0.845138527242795,0.6790157018019449,TNFRSF1A/RAC2/NOS3,3
Metabolism,Global and overview maps,hsa01232,Nucleotide metabolism,2/142,34/2914,0.058823529411764705,1.2071251035625516,0.2749120363323012,0.49957412452191985,0.845138527242795,0.6790157018019449,TYMP/PNP,2
Metabolism,Carbohydrate metabolism,hsa00051,Fructose and mannose metabolism,1/142,14/2914,0.07142857142857142,1.46579476861167,0.395346070968228,0.5039167813187362,0.845138527242795,0.6790157018019449,HK2,1
Metabolism,Lipid metabolism,hsa00071,Fatty acid degradation,1/142,14/2914,0.07142857142857142,1.46579476861167,0.395346070968228,0.5039167813187362,0.845138527242795,0.6790157018019449,ACSL5,1
Metabolism,Glycan biosynthesis and metabolism,hsa00534,Glycosaminoglycan biosynthesis - heparan sulfate / heparin,1/142,14/2914,0.07142857142857142,1.46579476861167,0.395346070968228,0.5039167813187362,0.845138527242795,0.6790157018019449,XYLT1,1
Metabolism,Global and overview maps,hsa01250,Biosynthesis of nucleotide sugars,1/142,14/2914,0.07142857142857142,1.46579476861167,0.395346070968228,0.5039167813187362,0.845138527242795,0.6790157018019449,HK2,1
Organismal Systems,Immune system,hsa04662,B cell receptor signaling pathway,2/142,35/2914,0.05714285714285714,1.1726358148893359,0.2325208438422685,0.5152059576405025,0.845138527242795,0.6790157018019449,CR2/RAC2,2
Organismal Systems,Immune system,hsa04650,Natural killer cell mediated cytotoxicity,3/142,56/2914,0.05357142857142857,1.0993460764587526,0.16987576390982007,0.5195045652397083,0.845138527242795,0.6790157018019449,TNFRSF10B/RAC2/FCGR3A,3
Organismal Systems,Endocrine system,hsa04910,Insulin signaling pathway,3/142,56/2914,0.05357142857142857,1.0993460764587526,0.16987576390982007,0.5195045652397083,0.845138527242795,0.6790157018019449,TRIP10/HK2/SOCS3,3
Environmental Information Processing,Signal transduction,hsa04024,cAMP signaling pathway,6/142,119/2914,0.05042016806722689,1.034678660196473,0.08741031521331646,0.527475807774618,0.845138527242795,0.6790157018019449,EDN1/ARAP3/EDN3/RAC2/BDNF/OXTR,6
Metabolism,Carbohydrate metabolism,hsa00500,Starch and sucrose metabolism,1/142,15/2914,0.06666666666666667,1.3680751173708918,0.32342663525414156,0.5282077527162324,0.845138527242795,0.6790157018019449,HK2,1
Metabolism,Glycan biosynthesis and metabolism,hsa00512,Mucin type O-glycan biosynthesis,1/142,15/2914,0.06666666666666667,1.3680751173708918,0.32342663525414156,0.5282077527162324,0.845138527242795,0.6790157018019449,GALNT5,1
Metabolism,Carbohydrate metabolism,hsa00520,Amino sugar and nucleotide sugar metabolism,1/142,15/2914,0.06666666666666667,1.3680751173708918,0.32342663525414156,0.5282077527162324,0.845138527242795,0.6790157018019449,HK2,1
Organismal Systems,Immune system,hsa04658,Th1 and Th2 cell differentiation,2/142,36/2914,0.05555555555555555,1.1400625978090766,0.1913576523626537,0.5305150486434341,0.845138527242795,0.6790157018019449,IL4R/IL12A,2
Organismal Systems,Endocrine system,hsa04924,Renin secretion,2/142,36/2914,0.05555555555555555,1.1400625978090766,0.1913576523626537,0.5305150486434341,0.845138527242795,0.6790157018019449,EDN1/EDN3,2
Cellular Processes,Cell growth and death,hsa04217,Necroptosis,3/142,58/2914,0.05172413793103448,1.0614375910636231,0.10695149894282102,0.5435933388015419,0.845138527242795,0.6790157018019449,TNFRSF1A/TNFRSF10B/IL1B,3
Human Diseases,Neurodegenerative disease,hsa05010,Alzheimer disease,6/142,121/2914,0.049586776859504134,1.0175765335816553,0.044689783127324786,0.5442156946351369,0.845138527242795,0.6790157018019449,WNT8A/TNFRSF1A/IL1B/IL6/TUBB6/CASP12,6
Environmental Information Processing,Signal transduction,hsa04020,Calcium signaling pathway,7/142,142/2914,0.04929577464788732,1.0116048403094624,0.03208518364563328,0.5450983269739724,0.845138527242795,0.6790157018019449,ITPKC/VEGFA/FGF2/MST1R/NOS3/GDNF/OXTR,7
Metabolism,Glycan biosynthesis and metabolism,hsa00514,Other types of O-glycan biosynthesis,1/142,16/2914,0.0625,1.2825704225352113,0.25648106202813004,0.5513172729350304,0.845138527242795,0.6790157018019449,GALNT5,1
Metabolism,Global and overview maps,hsa01212,Fatty acid metabolism,1/142,16/2914,0.0625,1.2825704225352113,0.25648106202813004,0.5513172729350304,0.845138527242795,0.6790157018019449,ACSL5,1
NA,NA,hsa03272,Virion - Hepatitis viruses,1/142,16/2914,0.0625,1.2825704225352113,0.25648106202813004,0.5513172729350304,0.845138527242795,0.6790157018019449,CLDN5,1
Cellular Processes,Cell motility,hsa04810,Regulation of actin cytoskeleton,5/142,101/2914,0.04950495049504951,1.0158973643843259,0.03679753704445216,0.5526016373476528,0.845138527242795,0.6790157018019449,RAC2/FGF2/LIMK2/ITGB3/CYFIP1,5
Human Diseases,Infectious disease: viral,hsa05170,Human immunodeficiency virus 1 infection,4/142,80/2914,0.05,1.026056338028169,0.053478134817753334,0.5533701680227463,0.845138527242795,0.6790157018019449,TNFRSF1A/RAC2/TLR2/LIMK2,4
Human Diseases,Cardiovascular disease,hsa05415,Diabetic cardiomyopathy,3/142,59/2914,0.05084745762711865,1.0434471234184772,0.07629600159218633,0.5553767464738367,0.845138527242795,0.6790157018019449,RAC2/CD36/NOS3,3
Cellular Processes,Cellular community - eukaryotes,hsa04530,Tight junction,3/142,60/2914,0.05,1.026056338028169,0.046150862519269066,0.5669797844130582,0.8564578789223671,0.6881100896175409,YBX3/RUNX1/CLDN5,3
Organismal Systems,Immune system,hsa04612,Antigen processing and presentation,1/142,17/2914,0.058823529411764705,1.2071251035625516,0.19382096575112862,0.5733024169112988,0.8564578789223671,0.6881100896175409,HSPA6,1
NA,NA,hsa04981,Folate transport and metabolism,1/142,17/2914,0.058823529411764705,1.2071251035625516,0.19382096575112862,0.5733024169112988,0.8564578789223671,0.6881100896175409,SLC22A6,1
Organismal Systems,Immune system,hsa04611,Platelet activation,3/142,61/2914,0.04918032786885246,1.0092357423227891,0.016496949342624533,0.578398331161114,0.8588338856634724,0.690019061736066,FCGR2A/NOS3/ITGB3,3
Metabolism,Metabolism of cofactors and vitamins,hsa00670,One carbon pool by folate,1/142,18/2914,0.05555555555555555,1.1400625978090766,0.13488912965537284,0.5942175210875483,0.8717562435116727,0.7004013642822033,MTHFD2,1
Metabolism,Metabolism of cofactors and vitamins,hsa00760,Nicotinate and nicotinamide metabolism,1/142,18/2914,0.05555555555555555,1.1400625978090766,0.13488912965537284,0.5942175210875483,0.8717562435116727,0.7004013642822033,PNP,1
Metabolism,Nucleotide metabolism,hsa00240,Pyrimidine metabolism,1/142,19/2914,0.05263157894736842,1.0800593031875463,0.0792286258964392,0.6141143139071505,0.8955833744479278,0.7195449667959721,TYMP,1
Environmental Information Processing,Signal transduction,hsa04371,Apelin signaling pathway,3/142,66/2914,0.045454545454545456,0.9327784891165174,-0.1250051905215703,0.6326134876644991,0.9017168594924377,0.7244728366276514,SPP1/EGR1/NOS3,3
Metabolism,Amino acid metabolism,hsa00330,Arginine and proline metabolism,1/142,20/2914,0.05,1.026056338028169,0.026460431107056807,0.6330420401334664,0.9017168594924377,0.7244728366276514,NOS3,1
Metabolism,Metabolism of cofactors and vitamins,hsa00830,Retinol metabolism,1/142,20/2914,0.05,1.026056338028169,0.026460431107056807,0.6330420401334664,0.9017168594924377,0.7244728366276514,BCO1,1
Genetic Information Processing,Information processing in viruses,hsa03250,Viral life cycle - HIV-1,1/142,20/2914,0.05,1.026056338028169,0.026460431107056807,0.6330420401334664,0.9017168594924377,0.7244728366276514,NELFE,1
Environmental Information Processing,Signal transduction,hsa04012,ErbB signaling pathway,2/142,46/2914,0.043478260869565216,0.8922229026331905,-0.166737631071217,0.6651418349971954,0.9248757730023978,0.7430795684272756,CDKN1A/MYC,2
Organismal Systems,Endocrine system,hsa04919,Thyroid hormone signaling pathway,2/142,46/2914,0.043478260869565216,0.8922229026331905,-0.166737631071217,0.6651418349971954,0.9248757730023978,0.7430795684272756,MYC/ITGB3,2
Metabolism,Lipid metabolism,hsa00565,Ether lipid metabolism,1/142,22/2914,0.045454545454545456,0.9327784891165174,-0.0716206514824774,0.6681755584547935,0.9248757730023978,0.7430795684272756,PLA2G5,1
Metabolism,Xenobiotics biodegradation and metabolism,hsa00983,Drug metabolism - other enzymes,1/142,22/2914,0.045454545454545456,0.9327784891165174,-0.0716206514824774,0.6681755584547935,0.9248757730023978,0.7430795684272756,TYMP,1
Genetic Information Processing,Translation,hsa03010,Ribosome,1/142,22/2914,0.045454545454545456,0.9327784891165174,-0.0716206514824774,0.6681755584547935,0.9248757730023978,0.7430795684272756,MRPL12,1
Human Diseases,Cardiovascular disease,hsa05412,Arrhythmogenic right ventricular cardiomyopathy,2/142,47/2914,0.0425531914893617,0.8732394366197183,-0.1982608869599438,0.6767558651874888,0.9313288068996403,0.7482641756830622,DSC2/ITGB3,2
Cellular Processes,Transport and catabolism,hsa04148,Efferocytosis,3/142,71/2914,0.04225352112676056,0.8670898631223963,-0.25657636692577307,0.6818616545827927,0.9313288068996403,0.7482641756830622,CD36/THBS1/ITGB3,3
Cellular Processes,Transport and catabolism,hsa04146,Peroxisome,1/142,23/2914,0.043478260869565216,0.8922229026331905,-0.11743137790289672,0.6844684598031404,0.9313288068996403,0.7482641756830622,ACSL5,1
Organismal Systems,Endocrine system,hsa04928,"Parathyroid hormone synthesis, secretion and action",2/142,48/2914,0.041666666666666664,0.8550469483568074,-0.2291541306151684,0.6880429144850404,0.9313288068996403,0.7482641756830622,EGR1/CDKN1A,2
Human Diseases,Neurodegenerative disease,hsa05022,Pathways of neurodegeneration - multiple diseases,7/142,163/2914,0.04294478527607362,0.8812753823554826,-0.35302632209083795,0.6925470786083068,0.9314024808248583,0.7483233680526252,WNT8A/TNFRSF1A/IL1B/IL6/TUBB6/BDNF/CASP12,7
Human Diseases,Neurodegenerative disease,hsa05016,Huntington disease,4/142,96/2914,0.041666666666666664,0.8550469483568074,-0.3268212498363467,0.6979203340405344,0.9314024808248583,0.7483233680526252,BBC3/TUBB6/BDNF/POLR2A,4
Metabolism,Carbohydrate metabolism,hsa00010,Glycolysis / Gluconeogenesis,1/142,24/2914,0.041666666666666664,0.8550469483568074,-0.1613622213488596,0.6999667229328376,0.9314024808248583,0.7483233680526252,HK2,1
Organismal Systems,Development and regeneration,hsa04360,Axon guidance,4/142,97/2914,0.041237113402061855,0.8462320313634384,-0.3485588566095677,0.7057508039943803,0.9314024808248583,0.7483233680526252,SEMA3G/RAC2/EFNA1/LIMK2,4
Organismal Systems,Digestive system,hsa04974,Protein digestion and absorption,2/142,50/2914,0.04,0.8208450704225352,-0.2891645564803701,0.7096526276969992,0.9314024808248583,0.7483233680526252,SLC1A5/COL4A1,2
Organismal Systems,Immune system,hsa04622,RIG-I-like receptor signaling pathway,1/142,25/2914,0.04,0.8208450704225352,-0.20358360363303665,0.7147088424288709,0.9314024808248583,0.7483233680526252,IL12A,1
Organismal Systems,Immune system,hsa04672,Intestinal immune network for IgA production,1/142,25/2914,0.04,0.8208450704225352,-0.20358360363303665,0.7147088424288709,0.9314024808248583,0.7483233680526252,IL6,1
Cellular Processes,Transport and catabolism,hsa04144,Endocytosis,3/142,76/2914,0.039473684210526314,0.8100444773906597,-0.37972599302452753,0.7260874944751828,0.9327504319685754,0.7494063620972014,ARAP3/CXCR1/HSPA6,3
Organismal Systems,Nervous system,hsa04722,Neurotrophin signaling pathway,2/142,52/2914,0.038461538461538464,0.7892741061755146,-0.34697849844645584,0.7300076404743365,0.9327504319685754,0.7494063620972014,IRAK3/BDNF,2
Organismal Systems,Endocrine system,hsa04916,Melanogenesis,2/142,53/2914,0.03773584905660377,0.7743821419080521,-0.37512005150216865,0.7397274180704434,0.9327504319685754,0.7494063620972014,WNT8A/EDN1,2
Human Diseases,Substance dependence,hsa05032,Morphine addiction,2/142,53/2914,0.03773584905660377,0.7743821419080521,-0.37512005150216865,0.7397274180704434,0.9327504319685754,0.7494063620972014,GABRE/GABRA6,2
Organismal Systems,Aging,hsa04213,Longevity regulating pathway - multiple species,1/142,27/2914,0.037037037037037035,0.7600417318727177,-0.2834732027339093,0.7420694568083841,0.9327504319685754,0.7494063620972014,HSPA6,1
Human Diseases,Cardiovascular disease,hsa05416,Viral myocarditis,1/142,27/2914,0.037037037037037035,0.7600417318727177,-0.2834732027339093,0.7420694568083841,0.9327504319685754,0.7494063620972014,RAC2,1
Human Diseases,Cancer: overview,hsa05207,Chemical carcinogenesis - receptor activation,3/142,78/2914,0.038461538461538464,0.7892741061755146,-0.426903675803315,0.7423932009545805,0.9327504319685754,0.7494063620972014,VEGFA/MYC/FGF2,3
Organismal Systems,Immune system,hsa04664,Fc epsilon RI signaling pathway,1/142,28/2914,0.03571428571428571,0.732897384305835,-0.32138588193133266,0.7547560301139643,0.9434450376424554,0.7579988057535517,RAC2,1
Organismal Systems,Endocrine system,hsa04921,Oxytocin signaling pathway,3/142,81/2914,0.037037037037037035,0.7600417318727177,-0.495647297469368,0.765407841210764,0.9465605994000822,0.7605019638574236,CDKN1A/NOS3/OXTR,3
Human Diseases,Substance dependence,hsa05030,Cocaine addiction,1/142,29/2914,0.034482758620689655,0.707625060709082,-0.3580832745803718,0.766822781231018,0.9465605994000822,0.7605019638574236,BDNF,1
Organismal Systems,Immune system,hsa04062,Chemokine signaling pathway,3/142,82/2914,0.036585365853658534,0.7507729302645139,-0.5180519521268203,0.772702530122516,0.9465605994000822,0.7605019638574236,CCL2/RAC2/CXCR1,3
Cellular Processes,Cell motility,hsa04814,Motor proteins,3/142,82/2914,0.036585365853658534,0.7507729302645139,-0.5180519521268203,0.772702530122516,0.9465605994000822,0.7605019638574236,MYO1G/TUBB6/KIF19,3
Human Diseases,Cancer: overview,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,1/142,30/2914,0.03333333333333333,0.6840375586854459,-0.3936554438420034,0.7782997881860251,0.9475139681271919,0.7612679357241027,TLR2,1
Organismal Systems,Endocrine system,hsa04915,Estrogen signaling pathway,2/142,58/2914,0.034482758620689655,0.707625060709082,-0.5089707696725552,0.7839748553163577,0.9475139681271919,0.7612679357241027,NOS3/HSPA6,2
Organismal Systems,Sensory system,hsa04750,Inflammatory mediator regulation of TRP channels,2/142,59/2914,0.03389830508474576,0.6956314156123179,-0.5344912199452607,0.7919958415915339,0.9475139681271919,0.7612679357241027,IL1R1/IL1B,2
Genetic Information Processing,"Folding, sorting and degradation",hsa04120,Ubiquitin mediated proteolysis,1/142,32/2914,0.03125,0.6412852112676056,-0.46173743297439185,0.7995977027613528,0.9475139681271919,0.7612679357241027,SOCS3,1
Environmental Information Processing,Signal transduction,hsa04150,mTOR signaling pathway,2/142,61/2914,0.03278688524590164,0.6728238282151928,-0.5844044304624786,0.8072586324114354,0.9475139681271919,0.7612679357241027,WNT8A/TNFRSF1A,2
Metabolism,Carbohydrate metabolism,hsa00562,Inositol phosphate metabolism,1/142,33/2914,0.030303030303030304,0.6218523260776783,-0.49438419193750144,0.8094717923546518,0.9475139681271919,0.7612679357241027,ITPKC,1
Environmental Information Processing,Signaling molecules and interaction,hsa04514,Cell adhesion molecules,3/142,88/2914,0.03409090909090909,0.6995838668373879,-0.6475842991205386,0.8126830116947391,0.9475139681271919,0.7612679357241027,SELPLG/CDH5/CLDN5,3
NA,NA,hsa04081,Hormone signaling,4/142,114/2914,0.03508771929824561,0.7200395354583642,-0.690061689298471,0.8170308115464614,0.9475139681271919,0.7612679357241027,HAMP/HCRTR2/OXTR/ITGB3,4
Organismal Systems,Endocrine system,hsa04927,Cortisol synthesis and secretion,1/142,34/2914,0.029411764705882353,0.6035625517812758,-0.5261816375400248,0.8188626307738256,0.9475139681271919,0.7612679357241027,NR4A1,1
Human Diseases,Infectious disease: bacterial,hsa05120,Epithelial cell signaling in Helicobacter pylori infection,1/142,34/2914,0.029411764705882353,0.6035625517812758,-0.5261816375400248,0.8188626307738256,0.9475139681271919,0.7612679357241027,CXCR1,1
Organismal Systems,Sensory system,hsa04742,Taste transduction,1/142,35/2914,0.02857142857142857,0.5863179074446679,-0.5571828146150398,0.8277937093953939,0.9475139681271919,0.7612679357241027,GABRA6,1
Cellular Processes,Cell motility,hsa04820,Cytoskeleton in muscle cells,4/142,119/2914,0.03361344537815126,0.6897857734643152,-0.7819195773860139,0.8423850777711097,0.9475139681271919,0.7612679357241027,DSC2/THBS1/COL4A1/ITGB3,4
Organismal Systems,Endocrine system,hsa04929,GnRH secretion,1/142,37/2914,0.02702702702702703,0.5546250475827941,-0.616984880510665,0.8443649362406461,0.9475139681271919,0.7612679357241027,SPP1,1
Metabolism,Global and overview maps,hsa01200,Carbon metabolism,1/142,38/2914,0.02631578947368421,0.5400296515937731,-0.6458698255155761,0.8520466112680456,0.9475139681271919,0.7612679357241027,HK2,1
Human Diseases,Neurodegenerative disease,hsa05014,Amyotrophic lateral sclerosis,3/142,96/2914,0.03125,0.6412852112676056,-0.8087833561233477,0.8566704371336163,0.9475139681271919,0.7612679357241027,TNFRSF1A/TUBB6/CASP12,3
Cellular Processes,Transport and catabolism,hsa04142,Lysosome,1/142,39/2914,0.02564102564102564,0.526182737450343,-0.6741275247594973,0.8593516812262991,0.9475139681271919,0.7612679357241027,SLC11A1,1
Environmental Information Processing,Signal transduction,hsa04152,AMPK signaling pathway,1/142,39/2914,0.02564102564102564,0.526182737450343,-0.6741275247594973,0.8593516812262991,0.9475139681271919,0.7612679357241027,CD36,1
Organismal Systems,Endocrine system,hsa04918,Thyroid hormone synthesis,1/142,39/2914,0.02564102564102564,0.526182737450343,-0.6741275247594973,0.8593516812262991,0.9475139681271919,0.7612679357241027,ALB,1
Human Diseases,Substance dependence,hsa05031,Amphetamine addiction,1/142,39/2914,0.02564102564102564,0.526182737450343,-0.6741275247594973,0.8593516812262991,0.9475139681271919,0.7612679357241027,ARC,1
Organismal Systems,Nervous system,hsa04723,Retrograde endocannabinoid signaling,2/142,70/2914,0.02857142857142857,0.5863179074446679,-0.792809320322026,0.8643194561654262,0.9475139681271919,0.7612679357241027,GABRE/GABRA6,2
Metabolism,Lipid metabolism,hsa00564,Glycerophospholipid metabolism,1/142,40/2914,0.025,0.5130281690140845,-0.701791744919345,0.8662984851448612,0.9475139681271919,0.7612679357241027,PLA2G5,1
Organismal Systems,Endocrine system,hsa04914,Progesterone-mediated oocyte maturation,1/142,40/2914,0.025,0.5130281690140845,-0.701791744919345,0.8662984851448612,0.9475139681271919,0.7612679357241027,CDK2,1
Organismal Systems,Digestive system,hsa04971,Gastric acid secretion,1/142,40/2914,0.025,0.5130281690140845,-0.701791744919345,0.8662984851448612,0.9475139681271919,0.7612679357241027,KCNJ16,1
Organismal Systems,Digestive system,hsa04976,Bile secretion,1/142,40/2914,0.025,0.5130281690140845,-0.701791744919345,0.8662984851448612,0.9475139681271919,0.7612679357241027,SLC4A5,1
Cellular Processes,Cell growth and death,hsa04114,Oocyte meiosis,1/142,43/2914,0.023255813953488372,0.47723550605961346,-0.7815225538740057,0.8851596401364443,0.9489378964963388,0.7624119726952324,CDK2,1
Cellular Processes,Cellular community - eukaryotes,hsa04540,Gap junction,1/142,43/2914,0.023255813953488372,0.47723550605961346,-0.7815225538740057,0.8851596401364443,0.9489378964963388,0.7624119726952324,TUBB6,1
Organismal Systems,Endocrine system,hsa04922,Glucagon signaling pathway,1/142,43/2914,0.023255813953488372,0.47723550605961346,-0.7815225538740057,0.8851596401364443,0.9489378964963388,0.7624119726952324,LOC102724428,1
Human Diseases,Cancer: overview,hsa05231,Choline metabolism in cancer,1/142,43/2914,0.023255813953488372,0.47723550605961346,-0.7815225538740057,0.8851596401364443,0.9489378964963388,0.7624119726952324,RAC2,1
Human Diseases,Drug resistance: antineoplastic,hsa01522,Endocrine resistance,1/142,44/2914,0.022727272727272728,0.4663892445582587,-0.8071007781664663,0.8908396579353384,0.9489378964963388,0.7624119726952324,CDKN1A,1
Environmental Information Processing,Signal transduction,hsa04070,Phosphatidylinositol signaling system,1/142,44/2914,0.022727272727272728,0.4663892445582587,-0.8071007781664663,0.8908396579353384,0.9489378964963388,0.7624119726952324,ITPKC,1
Organismal Systems,Endocrine system,hsa04912,GnRH signaling pathway,1/142,46/2914,0.021739130434782608,0.44611145131659524,-0.856898791499522,0.9013761512082678,0.9560050088572536,0.7680899534105541,EGR1,1
Organismal Systems,Digestive system,hsa04972,Pancreatic secretion,1/142,47/2914,0.02127659574468085,0.43661971830985913,-0.8811594975997498,0.9062592009043717,0.9570409664722892,0.7689222802591539,PLA2G5,1
Organismal Systems,Endocrine system,hsa04925,Aldosterone synthesis and secretion,1/142,51/2914,0.0196078431372549,0.40237503452085055,-0.9743633663334066,0.9235043913585379,0.9710668492825827,0.7801911957716133,NR4A1,1
Human Diseases,Substance dependence,hsa05034,Alcoholism,2/142,86/2914,0.023255813953488372,0.47723550605961346,-1.1136107311699424,0.9292822645696155,0.9729664735878454,0.7817174245367436,BDNF/H4C2,2
Human Diseases,Cardiovascular disease,hsa05414,Dilated cardiomyopathy,1/142,54/2914,0.018518518518518517,0.38002086593635886,-1.0406597034124998,0.9343349434486677,0.9740938772124409,0.7826232225079547,ITGB3,1
Metabolism,Nucleotide metabolism,hsa00230,Purine metabolism,1/142,59/2914,0.01694915254237288,0.34781570780615895,-1.145278441482708,0.9491053654958008,0.9814865930233194,0.788562805135814,PNP,1
Organismal Systems,Environmental adaptation,hsa04714,Thermogenesis,1/142,61/2914,0.01639344262295082,0.3364119141075964,-1.1853058102675815,0.9540430289343953,0.9814865930233194,0.788562805135814,ACSL5,1
Organismal Systems,Endocrine system,hsa04935,"Growth hormone synthesis, secretion and action",1/142,61/2914,0.01639344262295082,0.3364119141075964,-1.1853058102675815,0.9540430289343953,0.9814865930233194,0.788562805135814,SOCS3,1
Organismal Systems,Nervous system,hsa04726,Serotonergic synapse,1/142,64/2914,0.015625,0.3206426056338028,-1.2436084528682736,0.9605714595529427,0.9814865930233194,0.788562805135814,ALOX12B,1
Human Diseases,Cancer: overview,hsa05208,Chemical carcinogenesis - reactive oxygen species,1/142,66/2914,0.015151515151515152,0.31092616303883913,-1.2814024133147641,0.9644032533735545,0.9814865930233194,0.788562805135814,VEGFA,1
Human Diseases,Neurodegenerative disease,hsa05012,Parkinson disease,1/142,68/2914,0.014705882352941176,0.3017812758906379,-1.3183972883600865,0.9678650286591849,0.9814865930233194,0.788562805135814,TUBB6,1
Environmental Information Processing,Signal transduction,hsa04072,Phospholipase D signaling pathway,1/142,69/2914,0.014492753623188406,0.2974076342110635,-1.3366097908740435,0.969468389843442,0.9814865930233194,0.788562805135814,CXCR1,1
NA,NA,hsa04082,Neuroactive ligand signaling,2/142,124/2914,0.016129032258064516,0.33098591549295775,-1.7229068725986114,0.9864111343802235,0.9925462794260298,0.7974485682176911,GABRE/GABRA6,2
Environmental Information Processing,Signal transduction,hsa04022,cGMP-PKG signaling pathway,1/142,88/2914,0.011363636363636364,0.23319462227912935,-1.6529442605681943,0.9884950701222501,0.9925462794260298,0.7974485682176911,NOS3,1
Metabolism,Global and overview maps,hsa01100,Metabolic pathways,13/142,537/2914,0.024208566108007448,0.4967870537938993,-2.9217439890793013,0.9994632951374935,0.9994632951374935,0.8030059557066007,TYMP/MTHFD2/ITPKC/XYLT1/PLA2G5/BCO1/GALNT5/HK2/NOS3/ALOX12B/ACSL5/PNP/PDXP,13
